A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder

被引：0
|
作者：
Karla D. Wagner
Charles Marks
Phillip Fiuty
Robert W. Harding
Kimberly Page
机构：
[1] University of Nevada,School of Public Health
[2] The Mountain Center Harm Reduction Center,undefined
[3] University of New Mexico Health Sciences Center,undefined
来源：
Addiction Science & Clinical Practice | / 18卷
关键词：
Methamphetamine; Pharmacotherapies; Qualitative research; Patient-centered outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Underutilization of medications to treat opioid use disorder: What role does stigma play?
    Allen, Bennett
    Nolan, Michelle L.
    Paone, Denise
    SUBSTANCE ABUSE, 2019, 40 (04) : 459 - 465
  • [42] Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder
    Haass-Koffler, Carolina L.
    Perciballi, Roberta
    ALCOHOL AND ALCOHOLISM, 2020, 55 (02): : 129 - 135
  • [43] Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development
    Litten, Raye Z.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 (11) : 2299 - 2304
  • [44] Trajectories of methamphetamine use in the rural South: A longitudinal qualitative study
    Sexton, Rocky L.
    Carlson, Robert G.
    Leukefeld, Carl G.
    Booth, Brenda M.
    HUMAN ORGANIZATION, 2008, 67 (02) : 181 - 193
  • [45] Anti-craving medications for alcohol to treat moderate to severe alcohol use disorder
    Mong, Jon
    Ahamad, Keith
    Bach, Paxton
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (30) : E1196 - E1197
  • [46] Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder
    Keith G. Heinzerling
    Marisa Briones
    April D. Thames
    Charles H. Hinkin
    Tianle Zhu
    Ying Nian Wu
    Steven J. Shoptaw
    Journal of Neuroimmune Pharmacology, 2020, 15 : 238 - 248
  • [47] Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder
    Heinzerling, Keith G.
    Briones, Marisa
    Thames, April D.
    Hinkin, Charles H.
    Zhu, Tianle
    Wu, Ying Nian
    Shoptaw, Steven J.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2020, 15 (02) : 238 - 248
  • [48] Accessibility Barriers to Medications for Opioid Use Disorder Treatment: A Qualitative Study of Perspectives From Women With Opioid Use Disorder and Health and Criminal Justice Professionals
    Skogseth, Emma
    Brant, Kristina
    Latkin, Carl
    Jones, Abenaa
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [49] Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study
    Morse, Erica
    Binswanger, Ingrid A.
    Taylor, Emmeline
    Gray, Caroline
    Stimmel, Matthew
    Timko, Christine
    Harris, Alex H. S.
    Smelson, David
    Finlay, Andrea K.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 129
  • [50] Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder
    Banks, Matthew L.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2017, 1394 (01) : 92 - 105
12345